Pennsylvania seeks to collaborate with Delaware for HIE development

The Pennsylvania Governor’s Office of Healthcare Reform issued a strategic plan this month in the hope of streamlining the creation of a health information exchange (HIE) through a collaboration between the governments of Pennsylvania and Delaware.

The Pennsylvania Health Information Exchange (PHIX), according to the report, “is the next step to establishing a 21st century health IT infrastructure for Pennsylvania” to strengthen its healthcare system through timely, secure and authorized exchange of patient health information among healthcare providers.

In close alignment with the state Medicaid health IT plan, the Office of Healthcare Reform’s strategy is to leverage the capacity already developed by integrated and/or large healthcare systems, regional/sub-regional health information organizations and community hospitals to connect healthcare providers to improve the quality and efficiency of healthcare in Pennsylvania.

The approach includes exploring an intergovernmental agreement with Delaware for the use of the Delaware Health Information Network (DHIN) as a platform. Partnering with DHIN will "substantially accelerate start-up time" for PHIX and support clinicians in maximizing their incentive funds, the report stated.

“The DHIN platform is scalable to Pennsylvania’s needs and capable of handling the policies and procedures specific to Pennsylvania’s legal requirements independent of Delaware’s requirements,” the authors wrote.

According to the Office of Healthcare Reform, DHIN has already worked through many of the implementation issues and developed many of the shared services that will be needed during implementation of PHIX, including:
  • Compliance with the HIPAA’s privacy and security rules;
  • Building a master patient index and creating matching algorithms for locating patients and their records;
  • Usage monitoring protocols to ensure patient privacy and data security;
  • Creation of a disaster recovery program;
  • Mapping workflow and business processes; and
  • Creating test plans and processes.

The report is available for comment by interested parties until Dec. 20. A public meeting and information session is planned for Dec. 16 in Harrisburg, Pa.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.